Presentation TCT 2013

Anticoagulation and Antiplatelet Regimens After TAVR: Bivalirudin (BRAVO 2/3 Trial) and Other Alternatives

Presenter: George Dangas

October 28, 2013

REGISTER for free or LOG IN to view this content

Anticoagulation and Antiplatelet Regimens After TAVR: Bivalirudin (BRAVO 2/3 Trial) and Other Alternatives

Aortic Valve

Presentation

TCT 2013

Up Next

Presentation TCT 2013

Not So Fast! Patient Oriented Outcomes Are Not So Different with New Technology: Most MVD Patients Benefit by CABG

Presenter: Vasim Farooq

October 28, 2013

More slides +

Presentation TCT 2013

Effective Dashboards to Drive Quality Changes

Presenter: Judy Tingley

October 28, 2013

Presentation TCT 2013

Clinical Presentations, Indications for Intervention, and Relevant Anatomy

Presenter: Nicholas Morrissey

October 28, 2013

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.